Privacy

Cookie Policy

Contact

Home

ABOUT

Editorial

PRESS RELEASES

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR

SUBSCRIBE

Market Reports

FDA

Executives

Funding

Non Profits

Hospitals

Acquisitions

Health

Biotechnology News Magazine

Francesca DeMartino Named Sr VP of BD Investor Relations

Francesca DeMartino has been named senior vice president of BD investor relations for the company, effective Nov. 29.

In this role, DeMartino will lead all aspects of communicating progress of the BD2025 strategy to investors and the financial community, including the company’s initiatives that drive shareholder value. DeMartino will report to Chris DelOrefice, executive vice president and chief financial officer for BD. She succeeds Kristen Stewart who has been named senior vice president of enterprise strategy and insights for BD.

“Francesca is an accomplished leader with a long track record of success in investor relations, including extensive experience in the medical technology industry,” said DelOrefice. “She will lead BD’s efforts to highlight key milestones as we deliver on our strategy to drive growth through innovation.”

DeMartino has more than 20 years of combined experience in investor relations, communications and corporate finance, with her most recent position as vice president of investor relations at Medtronic. During her tenure, the function received IR Magazine awards for Best Overall Investor Relations and Best Investor Relations in Health Care. She had previously served as vice president of corporate communications and vice president of global communications for the Diabetes Group. Prior to joining Medtronic, DeMartino held positions of increasing responsibility at Johnson & Johnson, OMRIX Biopharmaceuticals, Macrocure Ltd, GCI Group and The Ruth Group. She began her career at Deutsche Bank AG as a financial analyst in the Health Care Investment Banking Group.

DeMartino holds a Bachelor of Arts in international and area studies from the University of California, Berkeley and a minor in business administration from the Walter A. Haas School of Business.

Other News

HypnoVR Raises €4.5 Million

The funds will allow HypnoVR to accelerate the commercial roll-out of its virtual reality-based medical hypnosis solution in France and globally. The company will also be stepping up efforts in its award-winning R&D program in order to further increase the therapeutic efficacy of its solution and broaden its scope of application to other medical and paramedical fields. 

Fluidx Medical Technology Announces Series A Led by Multinational Strategic Investor

Fluidx Medical Technology, a privately held medical device company founded to develop GPX, an innovative embolic material, and other technologies today announced the oversubscribed...

Trajan Group Acquires Axel Semrau GmbH

Trajan's automation business and Axel Semrau have worked in close cooperation for several years.

Alpheus Medical Closes $16M In Series A Financing For Novel Glioma Brain Cancer Treatment

Funds to support first-in-human (FIH) clinical trial of the company's proprietary, non-invasive sonodynamic drug-device therapy system for recurrent high-grade gliomas.
spot_img

By using this website you agree to accept Medical Device News Magazine Privacy Policy